Literature DB >> 25225205

Copeptin: a new biomarker that is specific for preeclampsia?

Denise C Cornelius1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25225205      PMCID： PMC4653040          DOI： 10.1161/HYPERTENSIONAHA.114.04255

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  10 in total

1.  Recent insights into the pathophysiology of preeclampsia.

Authors:  Eric M George; Joey P Granger
Journal:  Expert Rev Obstet Gynecol       Date:  2010-09-01

2.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

3.  Cardiovascular biomarkers in preeclampsia at triage.

Authors:  Sven Wellmann; Jörg Benzing; Silvia Fleischlin; Nils Morgenthaler; Sotirios Fouzas; Christoph A Bührer; Gabor Szinnai; Tilo Burkhardt; Olav Lapaire
Journal:  Fetal Diagn Ther       Date:  2014-05-17       Impact factor: 2.587

Review 4.  Role of biomarkers in early detection of preeclampsia.

Authors:  Manisha Kar
Journal:  J Clin Diagn Res       Date:  2014-04-15

5.  A proposed relationship between vasopressinase altered vasopressin and preeclampsia.

Authors:  J H Krege; V L Katz
Journal:  Med Hypotheses       Date:  1990-04       Impact factor: 1.538

6.  Maternal and neonatal copeptin levels at cesarean section and vaginal delivery.

Authors:  Ashraf A Foda; Ibrahim A Abdel Aal
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2012-08-22       Impact factor: 2.435

7.  Circulating levels of copeptin, a novel biomarker in pre-eclampsia.

Authors:  Ebru Zulfikaroglu; Mine Islimye; Esra Aysin Tonguc; Ahmet Payasli; Ferruh Isman; Turgut Var; Nuri Danisman
Journal:  J Obstet Gynaecol Res       Date:  2011-04-19       Impact factor: 1.730

8.  Vasopressin in preeclampsia: a novel very early human pregnancy biomarker and clinically relevant mouse model.

Authors:  Mark K Santillan; Donna A Santillan; Sabrina M Scroggins; James Y Min; Jeremy A Sandgren; Nicole A Pearson; Kimberly K Leslie; Stephen K Hunter; Gideon K D Zamba; Katherine N Gibson-Corley; Justin L Grobe
Journal:  Hypertension       Date:  2014-07-07       Impact factor: 10.190

9.  Increased levels of copeptin before clinical diagnosis of preeclampsia.

Authors:  Edwina H Yeung; Aiyi Liu; James L Mills; Cuilin Zhang; Tuija Männistö; Zhaohui Lu; Michael Y Tsai; Pauline Mendola
Journal:  Hypertension       Date:  2014-09-15       Impact factor: 10.190

Review 10.  Copeptin and its potential role in diagnosis and prognosis of various diseases.

Authors:  Lidija Dobsa; Kido Cullen Edozien
Journal:  Biochem Med (Zagreb)       Date:  2013       Impact factor: 2.313
  10 in total
  3 in total

Review 1.  Introduction to the American Heart Association's Hypertension Strategically Focused Research Network.

Authors:  Paul Muntner; Richard C Becker; David Calhoun; Daian Chen; Allen W Cowley; Joseph T Flynn; Justin L Grobe; Srividya Kidambi; Theodore A Kotchen; Daniel T Lackland; Kimberly K Leslie; Yingchuan Li; Mingyu Liang; Augusta Lloyd; David L Mattson; Brenda Mendizabal; Mark Mitsnefes; Anand Nair; Gary L Pierce; Jennifer S Pollock; Monika M Safford; Mark K Santillan; Curt D Sigmund; Stephen J Thomas; Elaine M Urbina
Journal:  Hypertension       Date:  2016-02-22       Impact factor: 10.190

Review 2.  Preeclampsia and Pregnancy-Related Hypertensive Disorders.

Authors:  S Ananth Karumanchi; Joey P Granger
Journal:  Hypertension       Date:  2015-12-22       Impact factor: 10.190

Review 3.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.